Correlation between Ischaemia-modified Albumin and Intermediate-density Lipoprotein in Haemodialysis Patients with End-stage Renal Disease

By Kotani K   Kimura S   Kinugasa E   Ogata H   Caccavello R   Taniguchi N   Gugliucci A  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1541-1545

Field House Publishing

Access to resources Recommend Favorite

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R.   Scott Lesley J.   Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

High-risk End-stage Renal Disease Patients Converted from Conventional to Short Daily Haemodialysis

By He Q   Chen J     Zhang P   Xie W   Jiang H   Yuan J  

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 682-688

Field House Publishing

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K   Zussman B   Miller AK   Freed MI  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

n -Acetyl-Cysteine Reduces Homocysteine Plasma Levels After Single Intravenous Administration by Increasing Thiols Urinary Excretion

By Ventura P.   Panini R.   Pasini M.C.R.I.S.T.I.N.A.   Scarpetta G.   Salvioli G.  

Pharmacological Research, Vol. 40, Iss. 4, 1999-10 ,pp. : 345-350

Academic Press

Access to resources Recommend Favorite